- Report
- June 2024
- 200 Pages
Global
From €7535EUR$7,950USD£6,295GBP
- Report
- April 2023
- 110 Pages
Global
From €4502EUR$4,750USD£3,761GBP
- Report
- January 2022
- 60 Pages
Global
From €3744EUR$3,950USD£3,128GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1896EUR$2,000USD£1,584GBP
- Report
- February 2024
- 68 Pages
Global
From €3313EUR$3,495USD£2,767GBP
- Report
- May 2022
- 84 Pages
Global
From €1896EUR$2,000USD£1,584GBP
- Report
- September 2024
- 81 Pages
Global
From €3500EUR$3,956USD£3,026GBP
Premature labor is a major issue in women's health, with an estimated 15 million babies born prematurely each year. Premature labor is defined as labor that occurs before 37 weeks of gestation, and can lead to a variety of health complications for both mother and baby. The causes of premature labor are not fully understood, but risk factors include maternal age, smoking, and certain medical conditions.
The premature labor market is focused on providing treatments and interventions to reduce the risk of preterm birth and improve outcomes for both mother and baby. This includes medications, lifestyle interventions, and monitoring technologies. Additionally, the market includes products and services to support the care of premature babies, such as specialized infant formulas, incubators, and neonatal intensive care units.
Companies in the premature labor market include Abbott Laboratories, Merck & Co., Novartis AG, Pfizer Inc., and Johnson & Johnson. Show Less Read more